Skip to main content
. 2021 May 31;21:506. doi: 10.1186/s12879-021-06221-5

Table 4.

Clinical outcomes in the early use and late use groups

Early use group (n = 12) Late use group (n = 10) p-value
Time from diagnosis to discharge 27.8 ± 12.2 57.4 ± 22.5 0.024
Time from symptom to PCR-negative 25.0 (22.0–38.0) 37.5 ± (28.0–50.0) 0.190
Time from symptom to discharge 32.4 ± 13.1 60.0 ± 21.5 0.030
Time from corticosteroid use to discharge 25.6 ± 12.4 46.3 ± 22.7 0.096
Length of hospital stay 26.0 ± 11.4 53.9 ± 11.4 0.033
Overall mortality, No./Total (%) 1/12 (8.3%) 3/10 (30%) 0.293

PCR polymerase chain reaction

Continuous variables with normal distribution are shown as mean ± SD. Group comparisons were performed using independent sample t-test. Continuous non-normal distribution variables are shown as median interquartile range. and Mann-Whitney tests were used to compare the difference between groups